文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Renal cell carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.

作者信息

Powles T, Albiges L, Bex A, Comperat E, Grünwald V, Kanesvaran R, Kitamura H, McKay R, Porta C, Procopio G, Schmidinger M, Suarez C, Teoh J, de Velasco G, Young M, Gillessen S

机构信息

Barts Cancer Institute, Department of Medical Oncology, Queen Mary University of London and Royal Free London NHS Foundation Trust, London, UK.

Université Paris Saclay, Institut Gustave Roussy, Villejuif, France.

出版信息

Ann Oncol. 2024 Aug;35(8):692-706. doi: 10.1016/j.annonc.2024.05.537. Epub 2024 May 22.

DOI:10.1016/j.annonc.2024.05.537
PMID:38788900
Abstract
摘要

相似文献

[1]
Renal cell carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.

Ann Oncol. 2024-8

[2]
Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Ann Oncol. 2016-9

[3]
Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Ann Oncol. 2010-5

[4]
Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Ann Oncol. 2014-9

[5]
Renal cell carcinoma: ESMO clinical recommendations for diagnosis, treatment and follow-up.

Ann Oncol. 2009-5

[6]
Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Ann Oncol. 2012-10

[7]
Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†.

Ann Oncol. 2019-5-1

[8]
Renal cell carcinoma: diagnosis, staging, and surveillance.

AJR Am J Roentgenol. 2008-10

[9]
Renal cell carcinoma guideline.

Eur Urol. 2007-6

[10]
[Not Available].

Aktuelle Urol. 2015-11

引用本文的文献

[1]
Incidence and prevalence of organ toxicities in patients suffering from clear cell renal carcinoma treated with sunitinib and its impact on survival: a reference cancer center experience.

Front Oncol. 2025-8-20

[2]
Effectiveness and safety of nivolumab and ipilimumab in older adults with renal cell carcinoma: findings from a multicenter observational study in Poland.

Front Oncol. 2025-8-19

[3]
TROP-2 overexpression in papillary renal cell carcinoma supports its potential as a therapeutic target for antibody-drug-conjugate therapy.

World J Urol. 2025-9-1

[4]
Neoadjuvant therapy demonstrates both safety and clinical feasibility for renal cell carcinoma patients with tumor thrombus.

Discov Oncol. 2025-8-26

[5]
Glycosylation in kidney diseases.

Precis Clin Med. 2025-7-11

[6]
Clinicopathological Characteristics and Prediction of Postoperative Mortality Risk in Patients with Non-metastatic Sarcomatoid Renal Cell Carcinoma.

Technol Cancer Res Treat. 2025

[7]
Novel radiopharmaceuticals for molecular imaging of renal cell carcinoma.

BMJ Oncol. 2025-8-17

[8]
Immune Checkpoint Inhibitors (ICI) in Urological Cancers: A New Modern Era, but Not Generally Applied.

Int J Mol Sci. 2025-7-25

[9]
Explainable machine learning for predicting distant metastases in renal cell carcinoma patients: a population-based retrospective study.

Front Med (Lausanne). 2025-7-29

[10]
promotes the progression of clear cell renal cell carcinoma via the TNF-α/NF-κB axis.

Transl Androl Urol. 2025-7-30

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索